- Trial ID:
- Matthew Price
Inclusion Criteria: - The patient has documented paroxysmal, persistent, or permanent non-valvular AF (i.e., the patient has not been diagnosed with rheumatic mitral valve disease). - LAA closure with the WATCHMAN device is planned - The patient fulfills the FDA indication for WATCHMAN LAA closure - The patient or legal representative is able to understand and willing to provide written informed consent to participate in the trial - The patient is able and willing to return for required follow-up visits and examinations. - The patient is 18 years of age or older Exclusion Criteria: - Conditions other than atrial fibrillation that require anti-coagulation (e.g., a prosthetic heart valve) - Stroke within the previous 7 days - Hypersensitivity to edoxaban - Moderate or severe mitral stenosis - A need for aspirin at a dose of >81 mg a day - A need for on-going treatment with dual antiplatelet therapy with aspirin and clopidogrel - A need for on-going treatment with ticagrelor or prasugrel - No LAA closure device implanted during procedure - Procedural complication of LAA closure (e.g., stroke, systemic embolism, bleeding, vascular complication [e.g., groin hematoma >10cm, AV fistula, or pseudoaneurysm), or serious pericardial effusion) - Planned surgery or invasive procedure within 6±2 weeks of enrollment
- Catchpole Heather
Why isn't this trial accepting new patients?
The trial may have a limited enrollment number, reached its maximum, or come to the end of its enrollment period. View trials that are recruiting
How else can Scripps help me?
We have a broad range of physician expertise and specialized medical services available. You can find a doctor online, call 1-800-SCRIPPS (1-800-727-4777) for personal help, or see related Scripps services.
How can I find trials that are accepting new participants?
For more information, see a list of trials that are recruiting, or call the clinical research office at 858-648-6402 for help.